Literature DB >> 17074797

Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption.

Slavena Vylkova1, Namrata Nayyar, Wansheng Li, Mira Edgerton.   

Abstract

Human beta-defensin 2 (hBD-2) and hBD-3 have potent fungicidal activity in the micromolar range. Although little is known about their mechanism of action against Candida species, some similarities to the antifungal mechanism of salivary peptide histatin 5 (Hst 5) seem to exist. Since hBD-2 and hBD-3 have been reported to cause direct disruption of target cell membranes, we compared the effects of hBD-2 and hBD-3 on Candida albicans membrane integrity. Incubation of calcein-loaded C. albicans cells with a dose of hBD-2 lethal for 90% of the strains tested (LD(90)) resulted in a maximal dye efflux of only 10.3% +/- 2.8% at 90 min, similar to that induced by Hst 5. In contrast, an LD(90) of hBD-3 more than doubled calcein release from cells yet did not result in more than 24% of total release, showing that neither peptide caused gross membrane damage. As for Hst 5, killing of C. albicans cells by hBD-2 and hBD-3 was salt sensitive; however, Ca(2+) and Mg(2+) inhibited hBD-2 but not hBD-3 fungicidal activity. Pretreatment of C. albicans cells with sodium azide resulted in significantly decreased ATP release and susceptibility of cells to hBD-2 and hBD-3. However, hBD-3 killing was partially restored at concentrations of > or =0.8 microM, showing energy-independent mechanisms at higher doses. C. glabrata resistance to Hst 5, hBD-2, and hBD-3 is not a result of loss of expression of cell wall Ssa proteins. The candidacidal effects of hBD-2-hBD-3 and Hst 5-hBD-2 were additive, while the index of interaction between Hst 5 and hBD-3 was 0.717 (P < 0.05). Thus, the candidacidal action of hBD-2 shows many similarities to that of Hst 5 in terms of salt sensitivity, ion selectivity, and energy requirements while hBD-3 exhibits biphasic concentration-dependent mechanisms of candidacidal action complementary to those of Hst 5.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074797      PMCID: PMC1797696          DOI: 10.1128/AAC.00478-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Synergy, antagonism, and what the chequerboard puts between them.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

2.  Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands.

Authors:  M Mathews; H P Jia; J M Guthmiller; G Losh; S Graham; G K Johnson; B F Tack; P B McCray
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 3.  Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.

Authors:  J B Epstein; B Polsky
Journal:  Clin Ther       Date:  1998 Jan-Feb       Impact factor: 3.393

4.  Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.

Authors:  R Bals; X Wang; Z Wu; T Freeman; V Bafna; M Zasloff; J M Wilson
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

5.  Calcium blocks fungicidal activity of human salivary histatin 5 through disruption of binding with Candida albicans.

Authors:  J Dong; S Vylkova; X S Li; M Edgerton
Journal:  J Dent Res       Date:  2003-09       Impact factor: 6.116

6.  Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.

Authors:  Sophie Joly; Connie Maze; Paul B McCray; Janet M Guthmiller
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

7.  Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans.

Authors:  M Edgerton; S E Koshlukova; T E Lo; B G Chrzan; R M Straubinger; P A Raj
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

8.  Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis.

Authors:  Toyohiro Tanida; Tetsuro Okamoto; Atsuko Okamoto; Haiyan Wang; Toshihiro Hamada; Eisaku Ueta; Tokio Osaki
Journal:  J Oral Pathol Med       Date:  2003-11       Impact factor: 4.253

9.  Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5.

Authors:  Xuewei S Li; Molakala S Reddy; Didi Baev; Mira Edgerton
Journal:  J Biol Chem       Date:  2003-05-21       Impact factor: 5.157

10.  Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations.

Authors:  R I Lehrer; T Ganz; D Szklarek; M E Selsted
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more
  46 in total

1.  Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans.

Authors:  J Hua; R Yamarthy; S Felsenstein; R W Scott; K Markowitz; G Diamond
Journal:  Mol Oral Microbiol       Date:  2010-12       Impact factor: 3.563

2.  Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.

Authors:  Viswanatha Krishnakumari; Nandini Rangaraj; Ramakrishnan Nagaraj
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

Review 3.  On approaches to the functional restoration of salivary glands damaged by radiation therapy for head and neck cancer, with a review of related aspects of salivary gland morphology and development.

Authors:  R S Redman
Journal:  Biotech Histochem       Date:  2008-06       Impact factor: 1.718

Review 4.  Properties and mechanisms of action of naturally occurring antifungal peptides.

Authors:  Nicole L van der Weerden; Mark R Bleackley; Marilyn A Anderson
Journal:  Cell Mol Life Sci       Date:  2013-02-05       Impact factor: 9.261

5.  The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding.

Authors:  Woong Sik Jang; Xuewei Serene Li; Jianing N Sun; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

6.  A role for antimicrobial peptides in intestinal microsporidiosis.

Authors:  G J Leitch; C Ceballos
Journal:  Parasitology       Date:  2008-12-12       Impact factor: 3.234

7.  Normal human gingival epithelial cells sense C. parapsilosis by toll-like receptors and module its pathogenesis through antimicrobial peptides and proinflammatory cytokines.

Authors:  Raouf Bahri; Sèverine Curt; Dalila Saidane-Mosbahi; Mahmoud Rouabhia
Journal:  Mediators Inflamm       Date:  2010-05-03       Impact factor: 4.711

8.  Protective role of murine β-defensins 3 and 4 and cathelin-related antimicrobial peptide in Fusarium solani keratitis.

Authors:  Satya Sree N Kolar; Hasna Baidouri; Samuel Hanlon; Alison M McDermott
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

9.  Identification and mechanism of action of the plant defensin NaD1 as a new member of the antifungal drug arsenal against Candida albicans.

Authors:  Brigitte M E Hayes; Mark R Bleackley; Jennifer L Wiltshire; Marilyn A Anderson; Ana Traven; Nicole L van der Weerden
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

10.  The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis.

Authors:  Nadine Steubesand; Karlheinz Kiehne; Gabriele Brunke; Rene Pahl; Karina Reiss; Karl-Heinz Herzig; Sabine Schubert; Stefan Schreiber; Ulrich R Fölsch; Philip Rosenstiel; Alexander Arlt
Journal:  BMC Immunol       Date:  2009-06-12       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.